JCRU
Journal of Cancer Research Updates | Volume 2 Number 3
|
|
Alpha-Fetoprotein Producing Breast Cancer Cells: Case Report and Review of Literature - Pages 140-143
Recent Advances on Nanotechnology Applications to Cancer Drug Therapy - Pages 151-185
Nephron-Sparing Surgery in Renal Cell Carcinoma: Morbidity and Outcomes - Pages 224-227 Osteoid Osteoma as a Cause of Macrodactyly - Pages 228-231 |
Journal of Cancer Research Updates | Volume 2 Number 1
|
|
Acute Abdomen Syndrome Caused by a Perforated Gastrointestinal Stromal Tumor – A Case Report - Pages 10-13 Anti-Cancer and Anti-Microbial Activity Studies of Some Complexes of Trimethoprim An Audit to Evaluate the Clinical Safety and PSA Response of Firmagon® (Degarelix) in Patients with Advanced Metastatic Prostate Cancer - Pages 21-25 Template-Based Inverse Planning Simulated Annealing for CT-Based High-Dose-Rate Brachytherapy of Cervical Cancer: Feasibility Study - Pages 26-32
|
Journal of Cancer Research Updates | Volume 1 Number 2
|
|
Anti-Idiotype Antibodies in Cancer Treatment - Pages 153-161 M.M. Soldevilla, A. Lуpez-Dнaz de Cerio, S. Inogйs, F. Pastor, H. Villanueva and M. Bendandi DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.02.1 A Review on EZH2 and its Epigenetic Association with Breast Cancer - Pages 162-172 Recent Advances in Cancer Vaccines – An Update - Pages 173-180 Biological Significance of the Proteasome Subunit LMP2/b1i as a Tumor Suppressor in Human Uterine Leiomyosarcoma - Pages 181-188 The Dual Role Played by p21 May Influence the Apoptotic or Anti-Apoptotic Fate in Cancer - Pages 189-202 Increasing the Tumoricidal Activity of Daunomycin-pHPMA Conjugates Using Vitamin B12 as a Targeting Agent - Pages 203-211 Inhibitors of Apoptosis Proteins (IAPs): Clinical Significance in Cancer Treatment Research - Pages 212-220 Peritoneal Carcinomatosis with Displaced IUCD - Pages 221-223 Second Look Proactive Surgery for Colon Cancer with Peritoneal Carcinomatosis - Pages 224-227 Expression of p63 in Squamous Cell Carcinoma of the Lung and its Diagnostic Significance: A Meta-Analysis - Pages 228-238 |
Journal of Cancer Research Updates - Volume 1 Number 1
|
|
|
Preface Primary Non-Hodgkin's Lymphoma of the Uterine Cervix: Report of Three Cases with Immunohistochemical Study - Pages 1-4 Extramedullary Plasmacytoma of the Lung – Rather a Disseminated than a Localized Disease? – A Case Report of a Primary Pulmonary Plasmacytoma Showing Distinct Signs of Systemic Spread - Pages 5-9 Topical Treatment of Skin Squamous Cell Carcinoma with Potassium Dobesilate Cream Moving EGFR Targeted Therapy into the Induction Phase of the Management of Squamous Cell Carcinoma of the Head and Neck - Pages 14-21 Does Tumour Biological Behaviour Influence Prognosis More than Diagnostic Delay in Oral Cancer? - Pages 22-27 Brain Tumor Stem Cells and Immunotherapy - Pages 28-38 Collision Primary Tumor of the Endometrium: Large Cell Neuroendocrine Carcinoma and Endometrioid Adenocarcinoma - Pages 39-43 Low Leukocyte MGMT Accompanies Temozolomide-Induced Myelotoxicity in Brain Tumor Patients - Pages 44-48 PAX3-FKHR Regulates the Expression of Pleiotrophin to Mediate Motility in Alveolar Rhabdomyosarcoma Cells - Pages 49-56 Transcriptional Modulation of the ERK1/2 MAPK and NF-kB Pathways in Human Urothelial Cells After Trivalent Arsenical Exposure: Implications for Urinary Bladder Cancer - Pages 57-68 Tissue-Engineered “Metastases”: Treatment of Hepatic Colon Tumors with a Dual Action Autotaxin Inhibitor-Lysophosphatidic Acid Receptor Antagonist - Pages 69-77 TAT-Mediated Delivery of p27 in Tumor Cell Lines as a Potential Therapeutic Peptide Mobile Phone Based Healthcare Platform for Assisting Lung Cancer Prevention - Pages 87-93 Present and Emerging Targeted Therapy for Metastatic Breast Cancer - Pages 94-101 EGFR Tyrosine Kinase Inhibitors Prolong Overall Survival in EGFR Mutated Non-Small-Cell Lung Cancer Patients with Postsurgical Recurrence - Pages 102-107 Treatment of Chemotherapy – Induced Peripheral Neuropathy: The Physicians Need Guidelines, the Patients Need Help - Pages 108-113 High-Expression of PTEN and an Absence of PCNA in Osteoclast-Like Multinucleated Giant Cells of Giant Cell Tumors in Bone - Pages 114-121 Biological Efficacy of a Dendritic Cell-Based Vaccine in a Patient with Metastatic Colorectal Cancer - Pages 122-128 Strategies of Targeting Tumors and Cancers - Pages 129-152 |
Editor in Chief- Profile
Prof. Zhe-Sheng (Jason) Chen received his M.D. degree from Guangdong Medical and Pharmaceutical College (now, named as Guangdong Pharmaceutical University), Master degree from Sun Yat-Sen University School of Public Health, China and Ph.D. degree from Kagoshima University Faculty of Medicine, Japan. He worked as a JSPS (Japanese Society for Promotion Science) fellow in Japan and a postdoctoral fellow in medical oncology at Fox Chase Cancer Center. Currently Dr. Chen is a Professor at St. John’s University College of Pharmacy and Health Sciences. Dr. Chen is also a director of Institute for Biotechnology at St. John’s University. His interests range from laboratory studies and clinical studies on drug resistance in leukemia, ovarian cancer, lung cancer and others. His Cancer Pharmacology laboratory is dedicated to find anticancer agents that, alone, or in combination with other agents to circumvent drug resistance in cancer treatment.
Dr. Chen is also an Editor-in-Chief of Journal of New Developments in Chemistry, an editor of African Journal of Pharmacy and Pharmacology and an associate editor of Journal of Analytical Oncology, Journal of Cancer Metastasis and Treatment and a guest editor of Current Pharmaceutical Biotechnology. Dr. Chen is an editorial board member of 26 journals and a reviewer of more than 170 peer reviewed journals. As a consultant to pharmaceutical, biotechnology and health industry organizations, Dr. Chen commands more than 150 invitations for presentations, keynote addresses, and conference chairman. He published more than 180 publications in peer reviewed journals. Dr. Chen is also a grant reviewer of NIH (USA), Chinese National Natural Science Foundation (China), The Genesis Oncology Trust (New Zealand), National Science Centre (Poland), The Government of the Hong Kong Special Administrative Region (HKSAR) Grant, Hong Kong (China), the Hungarian Scientific Research Fund (OTKA) (Hungary), the Netherlands Organisation for Scientific Research (NWO) (Netherlands), the Czech Science Foundation (Czech) and The Ministry of Education and Science of the Russian Federal etc.